Hemoglobinuria, Paroxysmal
3 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Danicopan for hemoglobinuria, paroxysmal | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Pozelimab + cemdisiran for hemoglobinuria, paroxysmal | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ruxoprubart for hemoglobinuria, paroxysmal | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |